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We review the role of neuroglial compartmentation and transcellular neurotransmitter
cycling during hypothalamic appetite regulation as detected by Magnetic Resonance
Imaging (MRI) and Spectroscopy (MRS) methods. We address first the neurochemical
basis of neuroendocrine regulation in the hypothalamus and the orexigenic and
anorexigenic feed-back loops that control appetite. Then we examine the main
MRI and MRS strategies that have been used to investigate appetite regulation.
Manganese-enhanced magnetic resonance imaging (MEMRI), Blood oxygenation
level-dependent contrast (BOLD), and Diffusion-weighted magnetic resonance imaging
(DWI) have revealed Mn2+ accumulations, augmented oxygen consumptions, and
astrocytic swelling in the hypothalamus under fasting conditions, respectively. High
field 1H magnetic resonance in vivo, showed increased hypothalamic myo-inositol
concentrations as compared to other cerebral structures. 1H and 13C high resolution
magic angle spinning (HRMAS) revealed increased neuroglial oxidative and glycolytic
metabolism, as well as increased hypothalamic glutamatergic and GABAergic
neurotransmissions under orexigenic stimulation. We propose here an integrative
interpretation of all these findings suggesting that the neuroendocrine regulation of
appetite is supported by important ionic and metabolic transcellular fluxes which begin at
the tripartite orexigenic clefts and become extended spatially in the hypothalamus through
astrocytic networks becoming eventually MRI and MRS detectable.
Keywords: appetite regulation, hypothalamus, neuroendocrine signaling, neuroglial compartmentation, magnetic
resonance imaging, magnetic resonance spectroscopy
The hypothalamus is a small cerebral structure responsible for the
integral homeostasis of vital systemic functions including global
energy metabolism, appetite, thirst and osmoregulation, ther-
moregulation, circadian rhythms, and some fundamental survival
responses such as aggressiveness (Swaab et al., 1992; Ganong,
1993; Lin et al., 2011). It operates as a highly sophisticated neu-
roendocrine transducer, sensing peripheral endocrine signals and
transforming them in intracerebral excitatory or inhibitory neu-
rotransmitter events that deliver the homeostatic response back to
the periphery (McEwen, 1989; Levin et al., 2011). Hypothalamic
function involves frequently the operation of highly elaborated
feed-back control loops (Figure 1).
Activation of the hypothalamic interface is thought to pro-
ceed essentially in two steps, an initial endocrine activation,
involving the receptor-mediated interaction of the hormone or
Abbreviations: MRI, Magnetic Resonance Imaging; MRS, Magnetic Resonance
Spectroscopy; MEMRI, Manganese-enhanced Magnetic Resonance Imaging;
BOLD, Blood Oxygenation Level-dependent contrast; DWI, Diffusion-weighted
Imaging; DIA, Dehydration-induced Anorexia.
neuropeptide with the presynaptic terminal, followed either by
the activation or inhibition of excitatory or inhibitory neuro-
transmitter release at the postsynaptic cleft. The neurotransmit-
ters glutamate and GABA play a central role in this process
mediating glutamatergic (Tong et al., 2007) or GABAergic (Xu
et al., 2012) neurotransmissions through specific neuronal path-
ways of the hypothalamus. These pathways trigger eventually
the release of hypothalamic neuropeptides or hormones to the
blood stream, to other hypothalamic structures and the hypoph-
ysis (McEwen, 1989; Thorburn and Proietto, 1998) or activate the
brain stem autonomic neurocircuitry (Palkovits, 1999), all these
events geared to maintain systemic homeostasis.
In the last decades, important progress has been reached
characterizing the initial endocrine step, identifying the cor-
responding systemic and intrahypothalamic neuropeptides and
receptors or the morphological pathways and tracts transmitting
these signals within the different hypothalamic nuclei or even
to extra-hypothalamic structures (McEwen, 1989; Lantos et al.,
1995). Progress has been slower, however, in the characterization
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FIGURE 1 | Schematic representation of the neuroendocrine interface
and feed-back control loops. Neuroendocrine integration may involve both,
neurons receiving endocrine signals and releasing neurotransmitters (A, C) or
neurons receiving neurotransmitter signals and releasing neuropeptides or
hormones (B, D). A typical feed-back control loop is illustrated. The initial
decrease in plasma concentration of an endocrine inhibitory effector (<[Ef]i ),
passes the blood brain barrier, releasing the inhibition of neuron A and
triggering action potentials (blue spikes) and the synaptic release of an
excitatory neurotransmitter as glutamate (blue circles). This activates
neuron B and triggers the release of an endocrine signal resulting eventually
in an increase in the final plasma concentration of the effector (>[Ef]f ).
Glutamatergic neurotransmission involves necessarily the operation of the
neuroglial glutamine cycle. The initial increase in the plasma concentration of
the effector (>[Ef]i ) inhibits neuron C, decreasing the frequency and
amplitude of the action potentials and triggering the release of an inhibitory
neurotransmitter as GABA (red circles). This causes neuron D to reduce or
suspend the release of the effector Ef, resulting eventually in an homeostatic
reduction in the plasma concentration of (<[Ef]f ),. GABAergic
neurotransmission involves necessarily the neuroglial glutamate-GABA cycle.
Both negative and positive feed-back loops tend to maintain the plasma
concentration of the effector Ef stable within a narrow range. Glu, glutamate;
Gln, glutamine; GABA, γ-aminobutyric acid.
of the neurotransmitter events underlying the neuroendocrine
response. In this respect, early interpretations conceived the
hypothalamic response as a neuronal only event. The evolu-
tion of the tripartite synapse concept (Araque et al., 1999;
Halassa et al., 2007; Santello et al., 2012), however, revealed
the essential role of astroglia in the modulation of synap-
tic neurotransmission, gaining for astrocytes a fundamental
role in neuroendocrine signaling (Garcia-Ovejero et al., 2005;
Garcia-Segura et al., 2008). In some important cases, as in
thyroid hormones, astrocytes are even required not only to
modulate synaptic transmission, but to generate the active
endocrine response (Mohacsik et al., 2011). Furthermore, glu-
tamatergic or GABAergic neurotransmissions involve neces-
sarily the operation of transcellular cycles of glutamate and
GABA between neurons and astrocytes (Hertz, 2004; Dienel
and Hertz, 2005), stressing the fundamental role of neu-
roglial compartmentation in hypothalamic function. However,
further improvements in our understanding of the role of
metabolic compartmentation in neuroendocrine function have
been often hampered by the limited accessibility of sufficiently
robust non-invasive methods to monitor neuronal activation
and transcellular neurotransmitter cycling in the hypothalamus
in vivo.
Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS)
approaches are known to be well endowed to observe hypotha-
lamic morphology and function. Briefly, Manganese-enhanced
MRI (MEMRI) techniques allow to monitor neuronal activa-
tion through the accumulation of Mn2+ and its effects in
T1-weighted images (Koretsky and Silva, 2004), Blood Oxygen
Level-dependent (BOLD) methods detect cerebral activation
through associated hemoglobin deoxygenation and perfusion
changes (Zhu et al., 1998; Logothetis and Wandell, 2004)
and Diffusion-weighted Imaging (DWI) visualize microstruc-
tural changes in the diffusion coefficient of water (Le Bihan,
2003), reflecting most probably activation induced neurocellular
swelling events. In addition, 1HMRS in vivo is able to characterize
the metabolic profile of the hypothalamus and its changes during
activation (Duarte et al., 2012) and 13C MRS provides com-
prehensive information on neuroglial oxidative metabolism and
neurotransmitter cycling (Cruz and Cerdan, 1999; Gruetter et al.,
2003; Rothman et al., 2003). Taken together, these techniques are
beginning to yield precious information on hypothalamic phys-
iology. However, a critical overview of the information gained
with the different methods and an integrative interpretation of
the results obtained becomes currently necessary, to be able to
recapitulate and design more precisely the protocols of future
strategies.
In this review, we examine the information gained thus far
with these approaches and provide an integrative interpretation
that highlights the vital role of hypothalamic neuroglial compart-
mentation in the cerebral control of global energy homeostasis
in vivo.
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HYPOTHALAMIC CONTROL OF APPETITE
Recent years have witnessed an important development in the
understanding of the hypothalamic mechanisms involved in
appetite control and global energy homeostasis (Coll et al., 2007).
Appetite control is currently understood to operate on the balance
of positive and negative peripheral signals from the adipose tissue,
the pancreas, and the gastrointestinal tract, modulating intrahy-
pothalamic and brain stem autonomic activities that determine
the early hunger or satiety responses and the long-term body
weight and energy balance (Schwartz and Morton, 2002; Morton
et al., 2006). Peripheral signals from the gut include mainly pep-
tide YY (PYY), oxyntomodulin (OXM), ghrelin, glucagon-like
peptide 1 (GLP-1), and colecystokinin (CCK). Adipose tissue,
pancreatic, and gut-derived peptides influence the hypothala-
mic circuitry providing short-term hunger or satiety signals and
resulting in the long term in anabolic (−) or catabolic (+) effects
in energy expenditure, increasing or decreasing body weight. In
particular, these mediators modulate the activation of the arcu-
ate (ARC), paraventricular (PVN), dorsomedial nuclei (DMN),
and ventromedial nuclei (VMN) of the hypothalamus which con-
trol food intake through a delicate balance of orexigenic and
anorexigenic pathways operated by specific neurons and neu-
ropeptides (Stanley et al., 2005).
Figure 2 illustrates our current views on the mechanism of
appetite control within the hypothalamus. Hypothalamic con-
trol of energy homeostasis involves the modulation of orex-
igenic (stimulation of food intake) and anorexigenic (satiety
signals) pathways, that determine the positive or negative bal-
ance between food intake and energy expenditure (Schwartz
et al., 2000; Schwartz and Morton, 2002; Morton et al., 2006).
Briefly, leptin and insulin produced by fat tissues and pan-
creas, circulate in blood in amounts proportional to body fat
and blood glucose. These long-term systemic effectors reach
easily the hypothalamic ARC nucleus, an area of relatively
permeable Blood Brain Barrier (BBB) and thus highly acces-
sible to activation by systemic effectors. Insulin and leptin,
inhibit the orexigenic Neuropeptide Y (NPY) and Agouti-related
Peptide (AgRP) neurons (purple) and activate the anorexi-
genic neurons (green) of the melanocortin (α-MSH)/cocaine and
amphetamine-regulated transcript (CART) pathways, resulting in
decreased food intake and increased energy expenditure. Long-
term increases in leptin or insulin lead to receptor desensitization
FIGURE 2 | Hypothalamic control of global energy balance. Appetite is
regulated by a complex feed-back loop involving endocrine signals originated
in peripheral tissues and intrahypothalamic peptides. Leptin and insulin inhibit
the orexigenic NPY/AgRP neurons (purple) and stimulate the anorexigenic
melanocortin neurons (green), resulting in a reduction of food intake. Ghrelin
or PYY3–36 activate or inhibit the NPY/AgRP neurons resulting in orexigenic or
anorexigenic responses, respectively. Taken from Schwartz and Morton
(2002). Reproduced with permission of the publisher.
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and insulin or leptin “resistance” increasing plasma glucose levels
and fat accumulation, producing eventually obesity and dia-
betes. Ghrelin and peptide PYY3−36, released by the stomach
and the colon, respectively, provide the Arcuate with positive
or negative short-term signals of appetite or satiety through
the selective activation or inhibition of the NPY/AgRP neurons,
resulting in hunger or satiety, respectively (Tang-Christensen
et al., 2004).
Despite these important advances in the understanding of the
endocrine processes controlling food intake and energy expendi-
ture, less is known on how these modify the neuroglial metabolic
coupling mechanisms supporting the activation or inhibition of
the orexigenic or anorexigenic pathways. However, important evi-
dence supports the crucial role of glutamatergic or GABAergic
neurotransmissions on hypothalamic function (Collin et al.,
2003; Hentges et al., 2004). In particular, intracerebral glutamate
administration is known to elicit an intense orexigenic response
(Stanley et al., 1993) while knock out mice in glutamate or
GABA vesicular transporters are known to exhibit altered feeding
behavior (Tong et al., 2007; Xu et al., 2012). Notably, how glu-
tamatergic or GABAergic neurotransmissions are modulated by
orexigenic or anorexigenic stimuli in vivo has not been directly
addressed.
MAGNETIC RESONANCE IMAGING STUDIES OF
HYPOTHALAMIC APPETITE REGULATION
MANGANESE-ENHANCED MAGNETIC RESONANCE IMAGING (MEMRI)
MEMRI is currently thought to directly reflect the neuronal accu-
mulation ofMn2+ through Voltage-dependent CalciumChannels
in stimulated brain areas, an event that extends transynaptically
and enables MEMRI to map neuronal connectivities (Pautler,
2004). Mn2+ accumulation may actually exceed the neuronal
tracts and extend to surrounding astrocytes and astrocytic net-
works, since abundant gap junctions exist in astrocytes (Andrew
et al., 1981) and neuronal activation has shown to elicit astro-
cytic intracellular and intercellular Ca2+ waves (Jaffe, 2006, 2008,
2010). Paramagnetic Mn2+ ions mimic closely the size of diamag-
netic Ca2+, thus providing an ideal surrogate probe to monitor
Ca2+ dynamics during neuronal activation. Hydrated Mn2+ ions
are classically known to induce a strong reduction in the T1 of
water, resulting in bright contrast in T1-weighted images in those
activated areas accumulating Mn2+ (Lee et al., 2005). MEMRI is
not devoid from limitations, sinceMn2+ administration is known
to become neurotoxic, competing with endogenous Ca2+ fluxes,
pertubing hypothalamic levels of metabolites and interfering with
the operation of vital metabolic pathways as the tricarboxylic
acid cycle and neurotransmitter cycles (Zwingmann et al., 2003,
2004).
Despite these limitations, MEMRI has been successfully used
to detect brain activity (Aoki et al., 2002) and neuronal archi-
tecture (Aoki et al., 2004) in rodents since the early 2000s, when
the first application to the study of hypothalamic functionality
appeared (Morita et al., 2002). Morita et al. detected increases in
T1-weighted images in the rat brain after intravenously infusing
MnCl2, but they had to disrupt the BBB for manganese to diffuse
properly through the brain. As an activation agent, they injected
NaCl to the rat brain and found signal increases in areas involved
in central osmotic regulation, including the hypothalamic area.
Their observations were validated by a positive correlation with
c-Fos expression levels in the activated areas and demonstrated,
for the first time to our knowledge, the possibility of studying
hypothalamic functionality with Mn2+-enhanced MRI, although
this required BBB disruption. Later on, in 2006, MEMRI was suc-
cessfully implemented without compromising the BBB (Yu et al.,
2005) to map regions of accumulated sound-evoked activity in
mice, after intraperitoneal administration of MnCl2. Soon after,
the first MEMRI study of hypothalamic activation associated with
feeding, without compromising the BBB (Kuo et al., 2006) was
published. Authors infused intravenously MnCl2 during the MRI
acquisition protocol and compared signal enhancement in the
hypothalamus of fed or overnight-fasted mice, obtaining signif-
icant differences in different hypothalamic nuclei. This revealed
that region-specific Mn2+ enhancement in the mouse brain could
be modulated by fasting. Since then, several MEMRI studies have
focused on the hypothalamic functionality associated to feed-
ing, by studying the effect of peptide administration and its
pathways of activation (Chaudhri et al., 2006; Parkinson et al.,
2009; Hankir et al., 2011), cerebral activation in transgenic mice
(Delgado et al., 2011) and hypothalamic response to alterations
of food intake (Just and Gruetter, 2011; Anastasovska et al.,
2012).
Finally, recent years have witnessed growing interest on
MEMRI applications, geared to a better understanding of the
molecular mechanisms by which Mn2+ produces alterations of
the hypothalamic physiological processes. In particular, a signifi-
cant number of publications focused on studies combingMEMRI
with other imaging or spectroscopic techniques (Delgado et al.,
2011; Just et al., 2011; Gutman et al., 2012), or even usingMEMRI
information to understand other functional techniques (Silva,
2012).
Figure 3 provides a useful frame for these concepts illustrat-
ing the use of MEMRI in the hypothalamus of control and obese
mice. Mn2+ infused in the tail vein of normal and obese mice
resulted in a larger increase in the intensity of the Arcuate and
VMN of obese animals as compared to the controls, a circum-
stance revealing the orexigenic stimulation of obese animals and
the high anatomical and neurophysiological resolution of the
approach.
BLOOD OXYGENATION LEVEL DEPENDENT (BOLD) CONTRAST
BOLD imaging is one of the most widely used techniques to
study brain function in animals and man, based on detecting
increases in oxygen consumption and associated hemodynamic
responses during neuronal activation. In the neuronal activa-
tion process, the ratio between deoxyhemoglobin (paramagnetic)
and oxyhemoglobin (diamagnetic) changes, and by studying this
ratio, BOLD (Ogawa et al., 1990) can successfully map brain
activity.
The use of functional neuroimaging in the study of appetite
control started in the late nineties, by monitoring the hypotha-
lamic function after glucose uptake in obese or lean humans
(Matsuda et al., 1999), demonstrating for the first time the
existence of differential hypothalamic function between lean
and obese subjects. Almost at the same time, BOLD imaging
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FIGURE 3 | Representative MEMRI response in obese and control mice.
Inset upper left: Localization of the hypothalamus, third and fourth ventricles
in an anatomical atlas (Paxinos and Franklin, 2001). Upper right: Mn2+
induced increase in MR signal intensity (MEMRI) in the arcuate nucleus (Arc),
ventromedial nucleus (VMH) and the fourth ventricle (V4). Lower panels:
Kinetics of MEMRI increase in VMH, Arc and V4 during and after Mn2+
infusion. Note that the obese animals (black squares) show a larger increase
in MEMRI than the controls (gray squares) in VMH and Arc, but not in V4,
revealing a specific obesity effect in these hypothalamic nuclei. Taken from
Delgado et al. (2011). Reproduced with permission of the publisher.
detected hypothalamic functionality in a rat model following
intraperitoneal glucose administration (Mahankali et al., 2000) by
recording significant decreases of the MRI signal in the hypotha-
lamic region after the injection. A few years later, a positive
correlation between blood-oxygenation-level-dependent (BOLD)
contrast fMRI and c-fos protein expression was established in
activated areas of the rat brain after the administration of anorex-
igenic agents (Stark et al., 2006), thus validating the use of BOLD
in anesthetized rats to identify the pathways of brain response
to appetite-modulating signals. Also in rats, different hypotha-
lamic response to glucose administration was detected in lean
and obese animals (Chen et al., 2007), with an attenuated BOLD
response in obese rats that was positively correlated with the
percentage of positive NPY cells in the hypothalamus, and with
significantly lower levels of 5-hydroxytryptamine (5-HT). Since
then, the use of BOLD imaging for the study of appetite regulation
in animals has generated an important number of contributions,
mainly related to the effects on hypothalamic activation after the
administration of different diets or peptides to rats (Min et al.,
2011; Li et al., 2012) and its correlation with endogenous levels of
neuropeptides.
In humans, early fMRI studies started investigating cerebral
activation with food pictures (Killgore et al., 2003) and the
hypothalamic response to different tastes and calories (Smeets
et al., 2005). It soon became clear that appetite in humans was
the result of very complex and interrelated neuronal circuits,
including not only hypothalamus and brainstem, which are the
principal homeostatic brain areas regulating body weight, but also
corticolimbic and higher cortical regions. Consequently, differ-
ent authors investigated the neuronal networks that responded
to specific orexigenic or anorexigenic signals (Batterham et al.,
2007; Miller et al., 2007; Malik et al., 2008). Currently, the
applications of BOLD fMRI on studies of appetite regulation
are mainly dedicated to the study of hypothalamic response to
glucose (Vidarsdottir et al., 2007; Purnell et al., 2011), to the
establishment of differences between fMRI responses in obese
and non-obese humans (Tomasi et al., 2009), and to the effects
of appetite modulating hormones derived from the gastrointesti-
nal tract and adipose tissue, mainly ghrelin (Jones et al., 2012),
insulin (Guthoff et al., 2010) and leptin (Baicy et al., 2007; Farooqi
et al., 2007).
Figure 4 illustrates a representative application of BOLD imag-
ing to appetite regulation in a study that monitored hypotha-
lamic activation in humans, as induced by a paradigm that
showed images of high- and low-calorie foods. Briefly, fMRI was
applied to investigate cerebral responses of 13 healthy women by
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FIGURE 4 | Statistical parametric maps of brain activated regions in
the human brain, as measured by BOLD, during the presentation of
high-calorie food images. The color bar reflects the scale of the SPM
statistic used for the analysis. The dorsolateral and medial prefrontal
cortex, the thalamus and the hypothalamus showed significant activation
(P < 0.005) relative to the control pictures of non-edible food related
utensils Reproduced from Killgore et al. (2003) with permission of the
publisher.
presenting three categories of images: high-calorie, low-calorie
and non-edible food-related utensils. They found areas of acti-
vation common to food stimuli regardless of the calorie con-
tent, such as the bilateral amygdala/hippocampus region. Besides,
high-calorie food stimuli were found to be associated with sig-
nificant clusters of activation within the medial and dorsolateral
prefrontal cortex, medial dorsal thalamus, hypothalamus, corpus
callosum, and cerebellum.
DIFFUSION-WEIGHTED IMAGING (DWI)
Diffusion-weighted Imaging (DWI) provides information on the
diffusion behavior of water molecules in biological tissues, and
can be used to probe and define tissue structures at micro-
scopic scales (Le Bihan, 2003). Since its introduction in 1985, it
is the modality of choice for the assessment of stroke in patients
(Schellinger et al., 2000) and for studies of white matter diseases
(Hagmann et al., 2007).
The interpretation of the biophysical models underlying diffu-
sion changes observed in physiological or pathological states has
been a matter of debate in the last decades. Indeed, several mod-
els that overcome the conventional monoexponential approach of
diffusion (Le Bihan, 2003) have been proposed (Assaf et al., 2002;
Jensen and Helpern, 2010; Grinberg et al., 2011).
Conventional DWI has been used to the study of appetite
regulation in the hypothalamus (Alkan et al., 2008). This study
compared apparent diffusion coefficients (ADC) values in brain
regions of obese and non-obese human subjects. Among other
areas, the hypothalamus of obese subjects was found to have
higher ADC values than the hypothalamic areas of lean patients.
Results were explained as an alteration of fluid distribution
in obese subjects due to a vasogenic edema. In fact, it has
been demonstrated that consumption of fat-rich diets acti-
vates proinflammatory responses in the hypothalamus (De Souza
et al., 2005), and that, in mice, the ability of high fat diets
to induce obesity depends upon the neuronal expression of
the mediator of inflammatory signaling MyD88 (Kleinridders
et al., 2009). Furthermore, the relationship between hypotha-
lamic inflammation and obesity has become a matter of study
and debate (Wisse and Schwartz, 2009; Wang et al., 2012),
and DWI is ideally endowed to evaluate its existence in vivo
(Cazettes et al., 2011). Recent results from our laboratories
(Lizarbe et al., 2013) suggest that hypothalamic inflammation
may occur not only in obesity, but also transiently during fasting
states.
Some years ago, the behavior of diffusion in biological tis-
sues was suggested to represent slow and fast diffusion phases
of water that were modified during neuronal activation pro-
cess (Niendorf et al., 1996; Le Bihan et al., 2006). Since then,
several contributions have used the biphasic model to detect
and describe more precisely brain activation using DWI in man
and studies in vitro (Flint et al., 2009; Kohno et al., 2009; Aso
et al., 2013). Even model-free approaches have been proposed
that confirm and extend the results obtained with the biex-
ponential model (Lizarbe et al., 2013). The use of functional
DWI (fDWI) in the study of hypothalamic activation associ-
ated to feeding came also from this study. Our results showed
that the diffusion coefficients of water in the hypothalamus
changed with fasting in both mice and humans. In mice, it
became possible to detect changes in individual hypothalamic
nuclei, including the ARC, the DMN and the VMN. On these
grounds, the application of fDWI to the study of brain activa-
tion in general and hypothalamic activity in particular, appears
to open a new avenue within the functional neuroimaging field,
even in humans. Diffusion changes associated to activation are
thought to occur closer -temporally and spatially- to the acti-
vated areas than the physiological changes detected with BOLD
(Le Bihan et al., 2006), avoiding the use of potentially toxic
Mn+2 doses. Besides, the possibility of using DWI to detect
directional differences through the implementation of Diffusion
Tensor Imaging approaches (Le Bihan et al., 2001; Ahn and Lee,
2011) may allow the investigation of neuronal tracts and their
potential alterations under different kinds of appetite-related
disturbances.
An example on the use of DWI imaging in the study of
hypothalamic activation is illustrated in Figure 5, through the
changes observed in the diffusion parameters of water in differ-
ent hypothalamic nuclei including the ARC, VMN, and DMN,
depicted in Figure 5A (Lizarbe et al., 2013). Panels 5B,D,F,
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FIGURE 5 | Imaging appetite by fDWI in the hypothalamic nuclei of
the mouse brain. (A) Axial MRI section containing the hypothalamus
in a representative mouse brain and in a brain atlas (inset) showing
the localization of the main periventricular hypothalamic nuclei:
Dorsomedial Nucleus (DMN, red), Ventromedial Nucleus (VMN, yellow),
and Arcuate Nucleus (Arc, blue). (B,D,F,H) Hypothalamic color maps of
diffusion parameters from fed or fasted mice, superimposed to T2w
images in different hypothalamic nuclei. The hypothalamic region is
depicted enlarged in the corresponding lower panels. (C,E,G,I) Dslow
bar graphs of parameter values corresponding to the (B,D,F,H) panels,
respectively. ∗p < 0.05, ∗∗∗p < 0.001. Reproduced from Lizarbe et al.
(2013) with permission of the publisher.
and H show parameter maps of the slow diffusion coefficient
(Dslow) of a representative mouse in the fed (left) or overnight-
fasted (right) state, in the hypothalamus, ARC, VMN, and
DMN nuclei, respectively. Bar graphs in panels 5C,E,G, and I
show mean values of the same parameter in six mice. The
significant increase of Dslow with fasting in all nuclei may be
interpreted as the consequence of activation-induced astrocytic
swelling.
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MULTINUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
STUDIES OF APPETITE REGULATION
The use of imaging methods may be complemented by sev-
eral advanced spectroscopy strategies including mainly 1H MRS
in vivo and ex vivo 1H and 13C HRMAS. These methods have
been shown to overcome the need to use large voxel volumes, a
limitation precluding earlier the applications of MRS in vivo to
hypothalamic physiology.
HIGH FIELD 1H MRS in vivo
High field 1H MRS (14.1 Tesla) has been shown to be able to
obtain high quality metabolic profiles from the mouse hypotha-
lamus in vivo either unilaterally (2.2μL voxels) or bilaterally
(4.4μL voxels) (Lei et al., 2010; Duarte et al., 2012). Authors
reported that the metabolic profile of the hypothalamus is
different from other cerebral structures as the hippocampus,
containing larger concentration of γ-aminobutyric acid andmyo-
inositol and lower concentrations of taurine (Figure 6A). High
field 1H MRS was used to characterize the effects of Mn2+ in the
metabolic profile of the rat hypothalamus under the paradigm of
Dehydration-induced Anorexia (DIA) (Just and Gruetter, 2011).
Results showed that γ-aminobutyric acid had an essential role
in the maintenance of energy homeostasis in the hypothala-
mus, independently of the condition investigated. Glutamate,
glutamine, and taurine, however, appeared to respondmore accu-
rately to Mn2+ exposure. When comparing DIA and overnight
fasting, GABA levels increased in both, but lactate increased sig-
nificantly only in DIA. Taken together, these studies showed that
high field 1H MRS in vivo coupled with MEMRI, could pro-
vide very relevant information on the hypothalamic mechanisms
involved in the control of food intake, global energy balance, and
body weight control in rodents.
13C AND 1H HIGH RESOLUTION MAGIC ANGLE SPINNING
SPECTROSCOPY
13C Magnetic Resonance Spectroscopy is a method that has
shown previously an enormous potential in the investigation of
neuroglial coupling mechanisms, both in vivo and in vitro (Cruz
and Cerdan, 1999; Gruetter et al., 2003; Rothman et al., 2003;
Rodrigues et al., 2009). However, the low natural abundance of
13C (1.1%) and the reduced sensitivity of the method, imposed
the use of relatively large voxel sizes in vivo, exceeding signifi-
cantly the dimensions of the hypothalamus. To overcome this,
a novel collection of High Resolution Magic Angle Spinning
(HRMAS) 13C methods ex vivo were implemented recently. By
acquiring NMR spectra of biopsy samples, inclined 54.7◦ with
respect to the static magnetic field, the dipolar couplings that
broaden the resonances in vivo are removed and high reso-
lution spectra similar to those obtained in solution, can be
obtained from samples as small as 5–10mg, a size comparable
with that of the rodent brain hypothalamus. Using this tech-
nology, authors investigated (Figure 6B) the effects of overnight
fasting and ghrelin administration on the metabolic profile and
the incorporation of 13C from (1-13C) glucose into hypothala-
mic metabolites (Violante et al., 2009). Overnight fasting induced
significant increases in 13C incoporation into (2-13C) GABA and
(3-13C) lactate, while the infusion of the orexigenic peptide ghre-
lin did not affect 13C labeling in these metabolites. These results
revealed that overnight fasting appears to increase GABAergic
neurotrasmission and glycolysis, but additional factors other
FIGURE 6 | Multinuclear NMR spectroscopy of the hypothalamus. (A) 1H
MRI in vivo from selected voxels of mouse hypothalamus (lower panels,
yellow region) as compared to the hippocampus (upper panels, red region)
and corresponding 1H NMR spectra. Note the relative increases in
hypothalamic GABA and myo-inositol (arrow up) and the decreases in
glutamate and taurine content (arrow down). Taken from Lei et al. (2010) and
reproduced with permission of the publisher. (B) Representative 13C HRMAS
of hypothalamic biopsies (top) prepared after (1-13C) glucose infusion as
compared to the rest of the brain (bottom) in a fasted mouse. Reproduced
from Violante et al. (2009) with permission of the publisher.
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than ghrelin were required to elicit this complex hypothalamic
response.
The neuroglial mechanisms underlying leptin signaling in the
hypothalamus were recently investigated in control and ob/ob
mice, combiningMEMRIwith 1H and 13CHRMAS and infusions
of (1-13C) glucose, a primarily neuronal substrate or (2-13C)
acetate, a predominantly glial substrate (Delgado et al., 2011).
Leptin defficient obese mice showed increased MEMRI con-
trast in the ARC and VMN (Figure 3) and augmented 13C
accumulation in the hypothalamic glutamate and glutamine car-
bons from (1-13C) glucose, but not from 13C acetate. Together,
this evidence showed for the first time that the increased
MEMRI effect associated to neuronal activation of the orexi-
genic pathways in the obese mice was accompanied by increased
oxidative metabolism and glutamate-glutamine cycling. Together
with earlier 13C HRMAS evidences on increased GABAergic
performance after overnight fasting, the picture emerges that
orexigenic stimulation results in increased glutamatergic and
GABAergic neurotransmission, implying augmented transcellu-
lar cycling of glutamate-glutamine and GABA between neurons
and astrocytes. Present results support the view that the synap-
tic transmission events supporting neuroendocrine signaling
in the hypothalamus follow similar neuroglial compartmenta-
tion mechanisms to other types of cerebral sensorial or motor
activations.
RECAPITULATION
In summary, the evidence accumulated recently by MRI and
MRS methodologies has contributed importantly to investigate
the role of metabolic compartmentation during neuroendocrine
regulation in the hypothalamus. Figure 7 provides an integrative
interpretation on the role of neuroglial compartmentation during
appetite regulation, as revealed by MEMRI, BOLD, DWI as well
as by 1H and 13C NMR spectroscopy.
Briefly, the firing of orexigenic neurons involves voltage depen-
dent Na+ and Ca2+ channels. Mn2+ substitutes Ca2+, accumu-
lating in excited neurons during depolarization (Koretsky and
Silva, 2004; Silva et al., 2004). In addition, glutamatergic neu-
rotransmission is known to be associated to intracellular and
intercellular astrocyte to astrocyte calcium waves transmitted
through gap junctions (Jaffe, 2006, 2008). Mn2+ could thus accu-
mulate in astrocytic networks as well. These astrocytic arrange-
ments may reach millimeter sizes, becoming then detectable
under conventional MRI resolution conditions. At present it is
not clear which neuronal or astroglial mechanism is predomi-
nant, but it can be safely thought that both contribute to the
observed MEMRI effect. Excess glutamate released to the orex-
igenic cleft under fasting or obese conditions, is recaptured by
surrounding astrocytes, by Na+ dependent cotransport mainly
through the GLAST/EAAT1 and GLT-1/EAAT2 transporters, in
a 3Na+ per glutamate stoichiometry (Anderson and Swanson,
2000). The three sodium ions incorporated in this way, are
extruded to the extracellular space, in exchange with two potas-
sium ions entering the astrocytic interior through the electrogenic
Na+/K+ ATPase (Glynn, 1993; Pellerin and Magistretti, 1994).
The astrocytic ATP required for the operation of the Na+/K+
ATPase and glutamine synthesis during activation by fasting,
is thought to be derived from increased glucose consumption
and metabolism by oxidative and glycolytic pathways in neu-
rons and astrocytes (Cerdan et al., 2006; Violante et al., 2009;
Delgado et al., 2011). Indeed, orexigenic stimulation results in
lactate accumulation in the hypothalamus and increased label-
ing of glutamate, glutamine and GABA from (1-13C) glucose as
reflected by 13C HRMAS. This reveals that hypothalamic acti-
vation by fasting involves the excitation of both glutamatergic
(activatory) and GABAergic (inhibitory) terminals, as expected
for an hypothalamic feed-back loop mechanism (Figure 1). In
addition, the increased metabolic demand in the hypothalamus
induced by fasting, results in an increased microvascular blood
flow and hemoglobin deoxygenation, a circumstance underlying
the changes observed by BOLD and DWI imaging (Lizarbe et al.,
2013).
The volume changes inferred in the hypothalamus during
orexigenic activation merit further attention. The K+ ions accu-
mulated in the extracellular space during the orexigenic action
potentials, may enter surrounding astrocytes through stimulation
of the Na+/K+/2Cl− cotransporter (Hertz et al., 2007), a circum-
stance that might trigger concomitant water influx and astrocytic
volume increase (Jayakumar and Norenberg, 2010), primarily-
mediated through the highly abundant aquaporin AQP-4 of
astrocytic membranes (Badaut et al., 2002). It should be noted
here that increased K+ concentrations are known to be tightly
coupled to neuronal activation, and have been detected using
metallographic microscopic imaging approaches (Goldschmidt
et al., 2004). In addition, EAAT1 glutamate sodium cotransporter
has been shown to cause water influx together with glutamate
transport (MacAulay et al., 2001) and the activation of the GABA
receptors GABAARs has been recently proposed to be involved
with cell volume regulation processes and water exchange in the
brain (Cesetti et al., 2011). On these grounds, increased astrocytic
volume may become an important determinant of the alter-
ations in diffusion parameters observed by DWI. The osmotic
swelling response associated to orexigenic stimulation, is pro-
posed here to occur initially in the few astrocytes surrounding
the activated orexigenic clefts (Figure 1), but can be rapidly
extended, to a plethora of neighboring astrocytes, through the
numerous interconnecting gap junctions of the network arrange-
ment (Halassa and Haydon, 2010) as mentioned above for Mn2+
accumulations.
The volume changes inferred by DWI find an adequate
support when considering the increases in hypothalamic myo-
inositol levels detected by high field 1HMRS (Lei et al., 2010). The
relative increases in osmolite content between the hypothalamus
and other areas of the brain as detected by 1H MRS in vivo, indi-
cate that volume regulation processes in the hypothalamus may
play an important role in hypothalamic function.
In summary, the above sections indicate that MRI and
MRS methodologies have provided important insight into
the hypothalamic mechanisms underlying appetite regulation.
Briefly, MEMRI approaches reveal neuroglial manganese accu-
mulation, BOLD shows concomitant oxygen consumption and
associated hemodynamic responses and DWI discloses water dif-
fusion changes compatible with glial swelling. 1H and 13C MRS
have revealed osmolite accumulation and increased glutamatergic
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FIGURE 7 | Integrative interpretation of orexigenic activation in the
hypothalamus as detected by MEMRI, BOLD, fDWI, and multinuclear
magnetic resonance spectroscopy. Neuroglial metabolic coupling
mechanisms and volume changes in astrocytes and capillaries of the
hypothalamus underlie the orexigenic response from resting (A) to
activated (B) states. Briefly, during orexigenic neurotransmission, excess
glutamate released to the synaptic cleft by AGRP/NPYY neurons (N, blue)
is recaptured by surrounding astrocytes (A, gray), together with 3Na+.
Intracellular sodium ions incorporated are extruded to the extracellular
space, through the electrogenic Na+/K+ATPase, incorporating two
intracellular K+ ions. Astrocytic glutamate produces glutamine, through
glutamine synthase, which is later recaptured by the neurons to operate
the glutamate-glutamine cycle. Additional K+ ions may be incorporated to
the astrocyte through the Na+K+2Cl− cotransporter, resulting in increased
intracellular K+ concentrations and thus triggering an osmotically driven,
aquaporin 4 (AQP4) mediated (blue channel), water transport, producing
astrocytic swelling. Glucose and oxygen are delivered through capillary to
astrocytes and neurons, and Mn2+ ions enter neurons and astrocytes
through calcium channels. Under resting conditions (A), oxidative
metabolism and glutamatergic neurotransmission depict basal levels
(dotted lines). Under activated orexigenic conditions (B), oxidative
metabolism and glutamatergic neurotransmission are increased (darker
lines, increased glutamate in the synaptic cleft) as revealed by 13C
HRMAS, resulting in augmented ionic and water trafficking to astrocytes
(darker arrows, increased water influx through AQP4). The accumulated K+
in one synaptic astrocyte may be transferred to the neighboring astroglia,
through gap junctions, providing a spreading mechanism for the swelling
response through the astrocyte syncytium, becoming measurable by fDWI.
Astrocytic volume changes are thought to underlie the increased
hypothalamic myo-inostol content observed by 1H HRMAS. Glucose and
oxygen demand increase (increasing capillary volume) during neuronal
activation, and the ratio between deoxyhemoglobin and oxyhemoglobin
changes causing the BOLD effect and the increased 13C labeling of
glutamate and GABA. Neuronal accumulation of Mn2+ through voltage
dependent calcium channels increase with neuronal activation (higher
number of channels and darker lines), causing the MEMRI effect.
and GABAergic neurotransmissions. Taken together, these results
suggest an important role for hypothalamic metabolic com-
partmentation during appetite regulation, as in other cere-
bral activations. Naturally, these interpretations do not exclude
additional contributions to MRI or MRS from other potential
mechanisms.
Finally, the approaches reviewed here may provide a valuable
tool to further investigate glutamatergic or GABAergic neuro-
transmissions in the hypothalamic control of global energy bal-
ance and in the development of improved treatments against
feeding disorders, obesity, and diabetes. In addition, this arsenal
of new methodologies may be easily extended to explore other
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hypothalamic functions, opening a new avenue in the research of
hypothalamic performance in vivo.
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